Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -16,663 | -10,715 | -5,997 | -15,868 |
| Depreciation Amortization | N/A | 517 | 343 | 167 | 373 |
| Accounts receivable | N/A | -1,197 | -1,543 | -289 | 144 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 827 | N/A |
| Other Working Capital | N/A | -3,065 | -6,096 | -4,455 | -1,230 |
| Other Operating Activity | 0 | 7,279 | 5,475 | 1,206 | 3,193 |
| Operating Cash Flow | $N/A | $-13,129 | $-12,536 | $-8,541 | $-13,388 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -490 | -422 | -326 | -472 |
| Purchase Of Investment | N/A | -49,550 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -142 | -104 | -36 | -163 |
| Other Investing Activity | 0 | -142 | -104 | -36 | -163 |
| Investing Cash Flow | $N/A | $-50,182 | $-526 | $-362 | $-635 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 69,172 | 69,169 | 69,137 | 1 |
| Other Financing Activity | 0 | -5,111 | -5,111 | -5,109 | -10 |
| Financing Cash Flow | $N/A | $64,061 | $64,058 | $64,028 | $-9 |
| Exchange Rate Effect | N/A | -31 | -15 | -11 | 158 |
| Beginning Cash Position | N/A | 59,966 | 59,966 | 59,966 | 73,840 |
| End Cash Position | N/A | 60,685 | 110,947 | 115,080 | 59,966 |
| Net Cash Flow | $N/A | $719 | $50,981 | $55,114 | $-13,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -13,129 | -12,536 | -8,541 | -13,388 |
| Capital Expenditure | N/A | -490 | -422 | -326 | -472 |
| Free Cash Flow | 0 | -13,619 | -12,958 | -8,867 | -13,860 |